146 related articles for article (PubMed ID: 10528815)
1. Platelet serotonergic binding sites in alcohol-dependent patients.
Arranz B; Rosel P; Sarró S; Zaldivar E; Cano R; Navarro MA; San L
Alcohol Alcohol; 1999; 34(5):726-32. PubMed ID: 10528815
[TBL] [Abstract][Full Text] [Related]
2. Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers.
Patkar AA; Berrettini WH; Lundy A; Murray HW; Hill KP; Vergare MJ; Weinstein SP
Hum Psychopharmacol; 2003 Mar; 18(2):103-11. PubMed ID: 12590403
[TBL] [Abstract][Full Text] [Related]
3. Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brains.
Rosel P; Arranz B; Vallejo J; Oros M; Crespo JM; Menchon JM; Navarro MA
Psychiatry Res; 1998 Jun; 82(3):161-70. PubMed ID: 9754440
[TBL] [Abstract][Full Text] [Related]
4. Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder.
Delorme R; Chabane N; Callebert J; Falissard B; Mouren-Siméoni MC; Rouillon F; Launay JM; Leboyer M
J Clin Psychopharmacol; 2004 Feb; 24(1):18-23. PubMed ID: 14709942
[TBL] [Abstract][Full Text] [Related]
5. Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity.
Preuss UW; Soyka M; Bahlmann M; Wenzel K; Behrens S; de Jonge S; Krüger M; Bondy B
Psychiatry Res; 2000 Sep; 96(1):51-61. PubMed ID: 10980326
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic administration of interferon alpha A/D on serotonergic receptors in rat brain.
Abe S; Hori T; Suzuki T; Baba A; Shiraishi H; Yamamoto T
Neurochem Res; 1999 Mar; 24(3):359-63. PubMed ID: 10215509
[TBL] [Abstract][Full Text] [Related]
7. Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain.
Gurevich EV; Joyce JN
Neuropsychopharmacology; 1996 May; 14(5):309-23. PubMed ID: 8703300
[TBL] [Abstract][Full Text] [Related]
8. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.
Owens MJ; Ballenger CA; Knight DL; Nemeroff CB
J Pharmacol Exp Ther; 1996 Sep; 278(3):1040-9. PubMed ID: 8819484
[TBL] [Abstract][Full Text] [Related]
9. Serotonin2 receptors and the serotonin transporter in the schizophrenic brain.
Dean B; Hayes W; Opeskin K; Naylor L; Pavey G; Hill C; Keks N; Copolov DL
Behav Brain Res; 1996; 73(1-2):169-75. PubMed ID: 8788497
[TBL] [Abstract][Full Text] [Related]
10. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet.
Coccaro EF; Kavoussi RJ; Sheline YI; Lish JD; Csernansky JG
Arch Gen Psychiatry; 1996 Jun; 53(6):531-6. PubMed ID: 8639036
[TBL] [Abstract][Full Text] [Related]
11. Aging alters in a region-specific manner serotonin transporter sites and 5-HT(1A) receptor-G protein interactions in hamster brain.
Duncan MJ; Hensler JG
Neuropharmacology; 2002 Jul; 43(1):36-44. PubMed ID: 12213257
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the platelet serotonin transporter by protein kinase C in the young and elderly.
Marazziti D; Rossi A; Masala I; Rotondo A; Palego L; Mazzoni M; Giannaccini G; Lucacchini A; Cassano GB
Biol Psychiatry; 1999 Feb; 45(4):443-7. PubMed ID: 10071715
[TBL] [Abstract][Full Text] [Related]
13. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.
Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of an aryl-azidoparoxetine. A novel photo-affinity probe for serotonin-transporter.
Chudzik J; McCarthy D; Bakish D; Ravindran A; Hrdina PD
Biochem Pharmacol; 1995 Oct; 50(8):1211-5. PubMed ID: 7488236
[TBL] [Abstract][Full Text] [Related]
15. The serotonin transporter from human brain: purification and partial characterization.
Rotondo A; Giannaccini G; Betti L; Chiellini G; Marazziti D; Martin C; Lucacchini A; Cassano GB
Neurochem Int; 1996 Mar; 28(3):299-307. PubMed ID: 8813248
[TBL] [Abstract][Full Text] [Related]
16. Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT(2A) receptors in Brodmann areas and brain hemispheres.
Rosel P; Arranz B; Urretavizcaya M; Oros M; San L; Vallejo J; Navarro MA
Psychiatry Res; 2002 Aug; 111(2-3):105-15. PubMed ID: 12374628
[TBL] [Abstract][Full Text] [Related]
17. Further studies on platelet serotonin transporter binding in depression.
Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
[TBL] [Abstract][Full Text] [Related]
18. Lower 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites.
Mann JJ; Henteleff RA; Lagattuta TF; Perper JA; Li S; Arango V
J Neural Transm (Vienna); 1996; 103(11):1337-50. PubMed ID: 9013420
[TBL] [Abstract][Full Text] [Related]
19. Chronic amitriptyline administration increases serotonin transporter binding sites in the hippocampus of aged rats.
Yau JL; Kelly PA; Olsson T; Noble J; Seckl JR
Neurosci Lett; 1999 Feb; 261(3):183-5. PubMed ID: 10081979
[TBL] [Abstract][Full Text] [Related]
20. Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients.
Marazziti D; Rossi A; Gemignani A; Giannaccini G; Pfanner C; Milanfranchi A; Presta S; Lucacchini A; Cassano GB
Neuropsychobiology; 1996; 34(4):184-7. PubMed ID: 9121618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
